AGP Executive Report
Last update: 4 hours agoNewborn Vaccine Trial: A controversial hepatitis B study in Guinea-Bissau has been cleared to proceed, with researchers planning to enroll 14,000 babies and delay the birth dose for half of them until six weeks. Critics say withholding a proven vaccine raises serious ethical concerns. Election Delay: Prime Minister Ilídio Vieira Té says December’s presidential and legislative elections cannot go ahead, with no new date set. Civil society groups also cite fears over political dissent and the unresolved killing of rapper and activist Vigário Luís Balanta. Regional Travel: Guinea-Bissau is among seven ECOWAS countries to launch the bloc’s biometric identity card, with mutual acceptance at regional borders targeted by December. Off the Pitch: Guinea-Bissau striker Flávio Silva spent the international break with his family in Zanzibar before returning to a busy run of club fixtures.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
